BIOMAT Database Logo BIOMAT Database Logo

Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents. 2002

Dhananjai J Menzies, and Pierre A Dorsainvil, and Burke A Cunha, and Diane H Johnson
Divisions of Cardiology and Infectious Disease, Winthrop-University Hospital, Mineola, New York 11501, USA.

UI MeSH Term Description Entries
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077734 Gatifloxacin A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS. 1-cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid,AM 1155,AM-1155,BMS-206584,CG 5501,Gatifloxacine,Tequin,Zymar,BMS 206584,BMS206584

Related Publications

Dhananjai J Menzies, and Pierre A Dorsainvil, and Burke A Cunha, and Diane H Johnson
Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents.
March 1989, Diabetes care,
Dhananjai J Menzies, and Pierre A Dorsainvil, and Burke A Cunha, and Diane H Johnson
[Hypoglycemia due to oral hypoglycemic agents: chance of adverse effects after restoration of blood glucose level].
May 2002, Nederlands tijdschrift voor geneeskunde,
Dhananjai J Menzies, and Pierre A Dorsainvil, and Burke A Cunha, and Diane H Johnson
Hypoglycemia from the inadvertent use of oral hypoglycemic agents.
January 1980, Annals of internal medicine,
Dhananjai J Menzies, and Pierre A Dorsainvil, and Burke A Cunha, and Diane H Johnson
Treatment of hypoglycemia secondary to hypoglycemic agents.
March 1966, Modern treatment,
Dhananjai J Menzies, and Pierre A Dorsainvil, and Burke A Cunha, and Diane H Johnson
Lactic acidosis and bone marrow suppression due to oral hypoglycemic agents.
August 1972, The Journal of the American Osteopathic Association,
Dhananjai J Menzies, and Pierre A Dorsainvil, and Burke A Cunha, and Diane H Johnson
[Hypoglycemic coma and oral hypoglycemic agents. Report of a case due to ingestion of chlorpropamide].
January 1967, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
Dhananjai J Menzies, and Pierre A Dorsainvil, and Burke A Cunha, and Diane H Johnson
Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation.
August 2004, Diabetes,
Dhananjai J Menzies, and Pierre A Dorsainvil, and Burke A Cunha, and Diane H Johnson
Severe and resistant hypoglycemia associated with concomitant gatifloxacin and glyburide therapy.
July 2004, Pharmacotherapy,
Dhananjai J Menzies, and Pierre A Dorsainvil, and Burke A Cunha, and Diane H Johnson
ORAL HYPOGLYCEMIC AGENTS.
September 1963, The Journal-lancet,
Dhananjai J Menzies, and Pierre A Dorsainvil, and Burke A Cunha, and Diane H Johnson
Oral hypoglycemic agents.
May 1967, Geriatrics,
Copied contents to your clipboard!